Skip to main content

Iron Deficiency

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
NCT02937454 | PHASE 4 | INTERVENTIONAL

Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency (Affirm-AHF)

Trial Information
16 Sites
1132 Participants
Recruiting
18 Years to 65 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

Hospital Universitario Austral
Buenos Aires,Argentina,1500
InCor Instituto do Corao HCFMUSP
São Paulo,Brazil,05403-900
Clinical Hospital Center Rijeka
Rijeka,Croatia
Aleksandre Aladashvili Clinic LLC
Tbilisi,Georgia,0102
The Baruch Pade Medical Center
Tiberias,Lower Galilee,Israel,15208
Hadassah Ein Kerem University Medical Center
Jerusalem,Israel,91120
Spedali Civilia di Brescia
Brescia,Italy
American University of Beirut Medical Center
Beirut,Lebanon,1107-2020
Vasculair Onderzoek Centrum
Hoorn,Netherlands
Clinical Military Hospital
Wroclaw,Poland,50-891
Emergency Clinical Hospital
Bucharest,Romania,014461
National Heart Centre of Singapore Pte
Singapore,Singapore,169609
University of Murcia
Murcia,Spain,30001
Skane University Hospital
Malmö,Sweden,SE20502
The M.D. Strazhesko Institute of Cardiology
Kyiv,Ukraine,02000
Kings College Hospital NHS Foundation
London,United Kingdom

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov